Cartography Biosciences

company

About

Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest, most effective targets.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$57M
Industries
Biopharma,Biotechnology,Life Science
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active

Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest and most effective targets.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$57M
Cartography Biosciences has raised a total of $57M in funding over 2 rounds. Their latest funding was raised on Jul 19, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 19, 2022 Series A $57M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Cartography Biosciences is funded by 2 investors. Gaingels and National Cancer Research Institute are the most recent investors.
Investor Name Lead Investor Funding Round
Gaingels Series A
National Cancer Research Institute Series A